April 5, 2017 / 12:18 PM / 4 months ago

BRIEF-Galmed Pharmaceuticals to present at International Liver Congress

1 Min Read

April 5 (Reuters) - Galmed Pharmaceuticals Ltd:

* Galmed Pharmaceuticals to present at international liver congress data that shows aramchol™ has a potential direct effect on liver fibrosis

* Data suggest a dual effect of aramchol on fibrosis and an improvement of fatty acid oxidation

* Data also suggest a direct impact on collagen producing cells which results in reversing fibrosis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below